Admin Nirvana Systems | Nirvana Systems Inc. - Part 6

All Posts by Admin Nirvana Systems

MEDIA ALERT: Beam Global to Perform World’s First Flying on Sunshine Flight in a Production Electric Aircraft in Reedley, California

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) — On Thursday October 29, Beam Global, a CleanTech leader that produces innovative, sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, will conduct the world’s first Flying on Sunshine flight in a Pipestrel, production electric aircraft, powered completely by Beam’s EV ARC™ unit delivering… Read […]

Continue reading

Peter Herweck Elected to Teradyne’s Board of Directors

NORTH READING, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) — Teradyne, Inc. (NASDAQ:TER) announced the election of Peter Herweck to its Board of Directors effective November 9, 2020. Mr. Herweck was also appointed to the Board’s Compensation and Nominating and Corporate Governance Committees. “We are excited to have Peter join Teradyne’s Board of Directors,” said Roy… Read […]

Continue reading

Conduent to Report Third-Quarter 2020 Financial Results on November 5, 2020

FLORHAM PARK, N.J., Oct. 26, 2020 (GLOBE NEWSWIRE) — Conduent Incorporated (NASDAQ:CNDT) plans to report its third-quarter 2020 financial results on Thursday, November 5, 2020, after market close. Management will present the results during a conference call and webcast at 5:00 p.m. ET. The call will be available by live audio webcast along with the… Read […]

Continue reading

SNGX: Cycle 3 Data for SGX301 Phase 3 Trial in CTCL Shows Continued Positive Effects…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Cycle 3 Data Shows Continued Efficacy for SGX301 in Phase 3 CTCL Trial On October 22, 2020, Soligenix, Inc. (NASDAQ:SNGX) announced data from Cycle 3 of the Phase 3 FLASH clinical trial of SGX301 in cutaneous T cell lymphoma (CTCL) shows continued […]

Continue reading

BCLI: Manufacturing Agreement with Catalent; Recent Sell-off Unwarranted…

By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Manufacturing Agreement with Catalent On October 22, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) announced an agreement with Catalent, Inc. (CTLT) for the manufacture of NurOwn®, which is currently being evaluated in a Phase 3 clinical trial in patients with amyotrophic lateral sclerosis […]

Continue reading

XIN: Xinyuan Real Estate, a developer of large-scale residential projects in China, benefits from China’s growing economy and positive demographic trends

By Steven Ralston, CFA NYSE:XIN READ THE FULL XIN RESEARCH REPORT Xinyuan Real Estate (NYSE:XIN) develops and sells real estate properties, primarily large-scale, high quality, multi-family residential projects in strategically selected high growth cities (Tier 1 and Tier 2) in China. In China, the company acquires land for development, primarily through public auctions of government […]

Continue reading

LTRN: Reviving Failed Oncology Drugs with AI

By John Vandermosten, CFA NASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT Initiating Coverage We are initiating coverage of Lantern Pharma Inc., (NASDAQ:LTRN) with a current valuation of $28 per share. Lantern is a new type of drug development company employing artificial intelligence and big data to identify critical biomarkers and relevant indications for previously investigated […]

Continue reading
>